Pyxis Oncology, Inc.

NasdaqGS:PYXS Stock Report

Market Cap: US$257.9m

Pyxis Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:PYXS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Sep 23BuyUS$14,960Pamela ConnealyIndividual8,000US$1.87
27 Sep 23BuyUS$11,868Pamela ConnealyIndividual6,426US$1.85
27 Sep 23BuyUS$4,675Jitendra WadhaneIndividual2,500US$1.87
25 Sep 23BuyUS$20,044Pamela ConnealyIndividual12,000US$1.67
25 Sep 23BuyUS$8,850Jitendra WadhaneIndividual5,000US$1.77
22 Sep 23BuyUS$8,695Pamela ConnealyIndividual5,000US$1.74
22 Sep 23BuyUS$4,349Jitendra WadhaneIndividual2,500US$1.74
18 Sep 23SellUS$18,161Lara SullivanIndividual8,641US$2.25
13 Sep 23SellUS$63,301Lara SullivanIndividual27,917US$2.27

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PYXS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5,6390.00958%
Hedge Funds3,170,8035.39%
VC/PE Firms4,184,1007.11%
Individual Insiders6,672,32911.3%
Public Companies8,694,60114.8%
Institutions12,981,97122%
General Public23,166,94739.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 55.6%.


Top Shareholders

Top 25 shareholders own 58.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
Ridgeback Capital Management LLC
5,956,443US$26.1m0%48.04%
10.1%
Pfizer Inc.
5,952,263US$26.1m0%no data
8.41%
Lara Sullivan
4,952,364US$21.7m316%no data
7.11%
Deep Track Capital, LP
4,184,100US$18.3m0%0.6%
5.39%
Laurion Capital Management LP
3,170,803US$13.9m0%0.5%
4.66%
Bayer Aktiengesellschaft
2,742,338US$12.0m0%no data
2.22%
The Vanguard Group, Inc.
1,306,685US$5.7m14.6%no data
1.84%
Pfizer Venture Investments LLC
1,080,507US$4.7m0%99.33%
1.2%
abrdn plc
708,303US$3.1m0%no data
1.06%
Pamela Connealy
624,231US$2.7m9.17%no data
0.75%
Vestal Point Capital, LP
440,000US$1.9m0%0.21%
0.65%
Hillhouse Investment Management, Ltd.
382,606US$1.7m0%0.01%
0.64%
John Flavin
377,796US$1.7m58.4%no data
0.62%
Renaissance Technologies LLC
364,150US$1.6m68.4%no data
0.56%
Decheng Capital LLC
326,810US$1.4m0%0.16%
0.53%
BlackRock, Inc.
310,598US$1.4m3.01%no data
0.52%
Geode Capital Management, LLC
308,241US$1.4m6.92%no data
0.4%
Bridgeway Capital Management, LLC
236,195US$1.0m0%0.02%
0.37%
Darren Cline
216,186US$946.9k181%no data
0.35%
Freda Lewis-Hall
206,186US$903.1k209%no data
0.28%
BNY Mellon Asset Management
162,108US$710.0k905%no data
0.26%
Jitendra Wadhane
154,971US$678.8k10.5%no data
0.21%
Dws Investment Gmbh
125,000US$547.5k0%no data
0.21%
Deutsche Asset & Wealth Management
125,000US$547.5k0%no data
0.19%
Harvest Investment Services, LLC
111,937US$490.3k-1.72%0.21%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.